FYERS
Home
/
Stocks
/
Results
/
Bafna Pharmaceuticals Results

Bafna Pharmaceuticals Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
6%16%9%3%
-14%-1%167%
-21%56%121%
-9%10%9%12%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
BAFNAPH-BE
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,849.9₹447476 Cr3712.0762.82₹11479 Cr
9,602₹254764 Cr87.134.04128.41₹2568 Cr
4,928.5₹189423 Cr86.8516.7297.06₹2163 Cr
1,180.3₹116658 Cr25.859.4262.53₹5040 Cr
1,399₹111484 Cr33.089.7757.87₹3879 Cr
2,026.2₹109943 Cr100.556.829.25₹889 Cr
2,500₹101712 Cr49.7913.7571.08₹1913 Cr
1,200.4₹101005 Cr31.355.3263.99₹4196 Cr
1,716₹99253 Cr26.7317.9596.84₹3505 Cr
2,100.7₹96031 Cr17.3730.95154.35₹5333 Cr
343.2₹810 Cr103.950.036.03₹11 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008
———————————————————
₹24 Cr₹24 Cr₹24 Cr₹24 Cr₹24 Cr₹24 Cr₹2 Cr₹24 Cr₹24 Cr₹19 Cr₹19 Cr₹19 Cr₹19 Cr₹19 Cr₹18 Cr₹17 Cr₹16 Cr₹16 Cr₹10 Cr
₹0₹0₹0₹0₹0₹0₹55 Cr₹0₹0₹4 Cr₹0₹0₹0₹3 Cr₹6 Cr₹3 Cr₹0₹0₹0
₹72 Cr₹61 Cr₹57 Cr₹50 Cr₹38 Cr₹33 Cr-₹7 Cr-₹3 Cr₹17 Cr₹22 Cr₹41 Cr₹53 Cr₹50 Cr₹46 Cr₹40 Cr₹34 Cr₹25 Cr₹23 Cr₹2 Cr
₹72 Cr₹61 Cr₹57 Cr₹50 Cr₹38 Cr₹33 Cr-₹7 Cr-₹3 Cr₹17 Cr₹22 Cr₹41 Cr₹53 Cr₹50 Cr₹46 Cr₹40 Cr₹34 Cr₹25 Cr₹23 Cr₹2 Cr
₹96 Cr₹85 Cr₹81 Cr₹73 Cr₹62 Cr₹57 Cr₹51 Cr₹21 Cr₹41 Cr₹45 Cr₹59 Cr₹72 Cr₹69 Cr₹67 Cr₹64 Cr₹54 Cr₹41 Cr₹39 Cr₹12 Cr
₹16 Cr₹13 Cr₹9 Cr₹7 Cr₹3 Cr₹3 Cr₹0₹21 Cr₹21 Cr₹37 Cr₹35 Cr₹10 Cr₹20 Cr₹23 Cr₹24 Cr₹31 Cr₹30 Cr₹23 Cr₹23 Cr
₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹0₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹0₹0₹0₹0₹0₹0₹4 L₹1 Cr₹2 Cr
₹0₹0₹0₹0₹0₹0₹0₹6 Cr₹5 Cr₹3 Cr₹3 Cr₹4 Cr₹6 Cr₹5 Cr₹5 Cr₹3 Cr₹2 Cr₹1 Cr₹12 L
₹4 Cr₹2 Cr₹2 Cr₹1 Cr₹85 L₹3 Cr₹0₹3 L₹3 L₹3 L₹3 L₹3 L₹93 L₹88 L₹61 L₹0₹0₹0₹0
₹42 L₹48 L₹39 L₹0₹0₹10 L₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹22 Cr₹16 Cr₹13 Cr₹10 Cr₹6 Cr₹5 Cr₹3 Cr₹29 Cr₹28 Cr₹42 Cr₹39 Cr₹14 Cr₹27 Cr₹29 Cr₹29 Cr₹34 Cr₹32 Cr₹25 Cr₹25 Cr
———————————————————
₹31 Cr₹31 Cr₹35 Cr₹28 Cr₹12 Cr₹11 Cr₹13 Cr₹39 Cr₹28 Cr₹23 Cr₹30 Cr₹35 Cr₹39 Cr₹72 Cr₹53 Cr₹25 Cr₹10 Cr₹13 Cr₹13 Cr
₹13 Cr₹11 Cr₹7 Cr₹5 Cr₹3 Cr₹4 Cr₹5 Cr₹8 Cr₹8 Cr₹14 Cr₹12 Cr₹12 Cr₹8 Cr₹6 Cr₹4 Cr₹2 Cr₹77 L₹90 L₹1 Cr
₹12 Cr₹9 Cr₹10 Cr₹12 Cr₹5 Cr₹10 Cr₹0₹23 Cr₹23 Cr₹43 Cr₹45 Cr₹53 Cr₹79 Cr₹68 Cr₹57 Cr₹20 Cr₹0₹0₹0
₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹2 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹50 L₹30 L₹19 L
₹57 Cr₹52 Cr₹54 Cr₹46 Cr₹22 Cr₹24 Cr₹17 Cr₹71 Cr₹59 Cr₹81 Cr₹87 Cr₹100 Cr₹126 Cr₹147 Cr₹114 Cr₹48 Cr₹11 Cr₹14 Cr₹14 Cr
₹176 Cr₹153 Cr₹148 Cr₹130 Cr₹90 Cr₹86 Cr₹71 Cr₹121 Cr₹128 Cr₹167 Cr₹185 Cr₹185 Cr₹223 Cr₹243 Cr₹207 Cr₹136 Cr₹84 Cr₹78 Cr₹51 Cr
₹20 Cr₹17 Cr₹18 Cr₹10 Cr₹6 Cr₹2 Cr₹5 Cr₹3 L₹46 L₹29 L₹3 Cr₹12 Cr₹18 Cr₹14 Cr₹14 Cr₹12 Cr₹7 Cr₹6 Cr₹5 Cr
₹37 Cr₹28 Cr₹24 Cr₹23 Cr₹11 Cr₹13 Cr₹3 Cr₹46 Cr₹47 Cr₹82 Cr₹80 Cr₹64 Cr₹99 Cr₹91 Cr₹81 Cr₹51 Cr₹30 Cr₹24 Cr₹25 Cr
———————————————————
₹134 Cr₹106 Cr₹99 Cr₹95 Cr₹88 Cr₹80 Cr₹74 Cr₹73 Cr₹73 Cr₹72 Cr₹72 Cr₹70 Cr₹85 Cr₹83 Cr₹82 Cr₹41 Cr₹37 Cr₹37 Cr₹4 Cr
₹52 Cr₹47 Cr₹59 Cr₹54 Cr₹49 Cr₹44 Cr₹39 Cr₹36 Cr₹33 Cr₹29 Cr₹25 Cr₹22 Cr₹22 Cr₹17 Cr₹12 Cr₹7 Cr₹5 Cr₹3 Cr₹2 Cr
₹82 Cr₹59 Cr₹40 Cr₹40 Cr₹39 Cr₹36 Cr₹35 Cr₹37 Cr₹40 Cr₹43 Cr₹47 Cr₹49 Cr₹63 Cr₹66 Cr₹70 Cr₹33 Cr₹32 Cr₹34 Cr₹2 Cr
₹3 Cr₹7 Cr₹10 Cr₹0₹0₹83 L₹21 L₹0₹0₹0₹0₹0₹0₹0₹0₹14 Cr₹6 Cr₹3 Cr₹21 Cr
₹5,000₹5,000₹0₹0₹0₹0₹0₹1 Cr₹1 Cr₹18 Cr₹18 Cr₹18 Cr₹1 Cr₹1 Cr₹1 Cr₹0₹0₹0₹0
₹5,000₹5,000₹0₹0₹0₹0₹0₹1 Cr₹1 Cr₹18 Cr₹18 Cr₹18 Cr₹1 Cr₹1 Cr₹1 Cr₹0₹0₹0₹0
₹96 L₹81 L₹73 L₹54 L₹42 L₹0₹0₹33 Cr₹37 Cr₹28 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹0₹0₹70 L₹0₹0₹0₹0₹100 L₹53 L₹58 L₹0₹86 L₹1 Cr₹2 Cr₹96 L₹21 L₹0₹0₹0
₹86 Cr₹67 Cr₹54 Cr₹42 Cr₹39 Cr₹37 Cr₹35 Cr₹72 Cr₹79 Cr₹90 Cr₹65 Cr₹68 Cr₹66 Cr₹69 Cr₹72 Cr₹47 Cr₹39 Cr₹37 Cr₹32 Cr
———————————————————
₹29 Cr₹28 Cr₹30 Cr₹22 Cr₹20 Cr₹15 Cr₹11 Cr₹9 Cr₹11 Cr₹17 Cr₹16 Cr₹15 Cr₹27 Cr₹21 Cr₹23 Cr₹15 Cr₹9 Cr₹5 Cr₹5 Cr
₹44 Cr₹40 Cr₹45 Cr₹41 Cr₹15 Cr₹10 Cr₹6 Cr₹25 Cr₹24 Cr₹54 Cr₹68 Cr₹83 Cr₹93 Cr₹85 Cr₹82 Cr₹35 Cr₹20 Cr₹24 Cr₹10 Cr
₹2 Cr₹3 Cr₹1 Cr₹8 Cr₹17 L₹2 Cr₹8 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹21 Cr₹2 Cr₹12 Cr₹2 Cr₹2 Cr₹1 Cr
₹2 Cr₹62 L₹57 L₹37 L₹27 L₹12 Cr₹7 Cr₹6 Cr₹5 Cr₹3 Cr₹2 Cr₹1 Cr₹4 Cr₹4 Cr₹3 Cr₹1 Cr₹79 L₹61 L₹40 L
₹13 Cr₹12 Cr₹17 Cr₹16 Cr₹15 Cr₹11 Cr₹3 Cr₹5 Cr₹6 Cr₹86 L₹30 Cr₹15 Cr₹22 Cr₹36 Cr₹22 Cr₹25 Cr₹12 Cr₹7 Cr₹2 Cr
₹90 Cr₹85 Cr₹94 Cr₹87 Cr₹51 Cr₹50 Cr₹36 Cr₹48 Cr₹48 Cr₹77 Cr₹119 Cr₹117 Cr₹149 Cr₹167 Cr₹132 Cr₹87 Cr₹44 Cr₹39 Cr₹19 Cr
₹32 Cr₹33 Cr₹40 Cr₹41 Cr₹29 Cr₹25 Cr₹19 Cr-₹22 Cr-₹11 Cr-₹4 Cr₹32 Cr₹18 Cr₹23 Cr₹21 Cr₹18 Cr₹40 Cr₹33 Cr₹25 Cr₹4 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹72 L₹0₹8 Cr₹6 Cr₹3 Cr₹1 Cr₹2 Cr₹2 Cr₹26 L
₹176 Cr₹153 Cr₹148 Cr₹130 Cr₹90 Cr₹86 Cr₹71 Cr₹121 Cr₹128 Cr₹167 Cr₹185 Cr₹185 Cr₹223 Cr₹243 Cr₹207 Cr₹136 Cr₹84 Cr₹78 Cr₹51 Cr
₹41₹36₹34₹31₹26₹24-₹19₹9₹17₹22₹31₹38₹33₹31₹30₹29₹25₹23₹12
₹41₹36₹34₹31₹26₹24-₹19₹9₹17₹22₹31₹38₹33₹31₹30₹29₹25₹23₹12

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008
₹11 Cr₹4 Cr₹7 Cr₹12 Cr₹5 Cr₹6 Cr-₹2 Cr-₹18 Cr-₹14 Cr-₹19 Cr-₹13 Cr₹6 Cr₹2 Cr₹5 Cr₹5 Cr₹5 Cr₹4 Cr₹2 Cr₹1 Cr
₹10 Cr₹10 Cr₹8 Cr₹8 Cr₹6 Cr₹4 Cr-₹20 Cr₹5 Cr-₹20 Cr₹15 Cr₹15 Cr-₹25 Cr₹19 Cr₹16 Cr₹10 Cr₹7 Cr₹4 Cr₹3 Cr₹88 L
-₹6 Cr₹8 Cr-₹5 Cr-₹14 Cr-₹80 L-₹23 Cr-₹12 Cr₹12 Cr₹27 Cr₹24 Cr-₹6 Cr₹30 Cr-₹20 Cr₹15 Cr₹13 Cr-₹17 Cr-₹8 Cr-₹19 Cr-₹4 Cr
₹15 Cr₹22 Cr₹10 Cr₹5 Cr₹10 Cr-₹14 Cr-₹34 Cr-₹1 Cr-₹7 Cr₹20 Cr-₹3 Cr₹12 Cr₹1 Cr₹36 Cr₹29 Cr-₹6 Cr-₹9 L-₹14 Cr-₹2 Cr
₹15 Cr₹22 Cr₹9 Cr₹5 Cr₹10 Cr-₹14 Cr-₹34 Cr-₹1 Cr-₹7 Cr₹20 Cr-₹3 Cr₹9 Cr₹77 L₹35 Cr₹28 Cr-₹6 Cr-₹59 L-₹14 Cr-₹2 Cr
-₹22 Cr-₹21 Cr-₹15 Cr-₹7 Cr-₹7 Cr-₹5 Cr₹33 Cr₹4 Cr₹38 Cr-₹14 Cr-₹1 Cr₹56 Cr-₹5 Cr-₹6 Cr-₹37 Cr-₹11 Cr-₹3 Cr-₹6 Cr-₹7 Cr
₹6 Cr₹1 Cr-₹85 L₹10 Cr-₹5 Cr₹12 Cr₹7 Cr-₹2 Cr-₹31 Cr-₹5 Cr₹4 Cr-₹66 Cr-₹14 Cr-₹11 Cr-₹51 L₹27 Cr₹4 Cr₹20 Cr₹8 Cr
-₹1 Cr₹2 Cr-₹6 Cr₹8 Cr-₹2 Cr-₹7 Cr₹6 Cr-₹21,000₹5 L-₹4 L₹25 L-₹2 L-₹18 Cr₹18 Cr-₹9 Cr₹10 Cr-₹19 L₹84 L-₹58 L
₹3 Cr₹1 Cr₹8 Cr₹17 L₹2 Cr₹8 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹21 Cr₹2 Cr₹12 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr
₹2 Cr₹3 Cr₹1 Cr₹8 Cr₹17 L₹2 Cr₹8 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹21 Cr₹2 Cr₹12 Cr₹2 Cr₹2 Cr₹1 Cr

Fundamental Ratios

Consolidated
Standalone

Share Price Live Stats

Open (₹)0.00
Volume (₹)0.00
High (₹)0.00
Upper Circuit343.20
Low (₹)0.00
Lower Circuit329.80
Prev Close336.50
52W High (₹)336.50
Price336.50
52W Low (₹)94.77

Share Market Cap & Key Ratios Overview

M.Cap (₹)809.52 Cr
Div. Yield (%)0.00
PE Ratio103.95
Debt to Equity0.39
Price to Book2.78
Book Value40.64
EPS (TTM)3.29
Face Value10.00
ROE (%)12.27

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
BAFNAPH-BENSE
LTP
1W Low
1W High
Market cap (₹)
1864.5+27.2 (1.48%)
1832.20
1891.50
4,47,476Cr
9607.5+232.5 (2.48%)
9312.50
9655
2,54,764Cr
4945.5+105.5 (2.18%)
4848.50
5010
1,89,423Cr
1168.5+8.5 (0.73%)
1152.10
1178
1,16,658Cr
1380-14.5 (-1.04%)
1364.50
1405.20
1,11,484Cr
2039.1+85.1 (4.36%)
1963.80
2050.80
1,09,943Cr
2466.7+166 (7.22%)
2303
2493
1,01,712Cr
1208.3+23.3 (1.97%)
1185
1222
1,01,005Cr
1728.2-5.8 (-0.33%)
1689.30
1739.30
99,253Cr
2098.6+15.6 (0.75%)
2080
2135
96,031Cr
336.5+19.3 (6.08%)
323.50
336.50
810Cr

Bafna Pharmaceuticals Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹3.57Cr; with other income of ₹-₹67.1Lakh, profit before interest and tax came to ₹2.21Cr. Interest expense was ₹2.5Lakh; PBT before exceptional items stood at ₹2.18Cr. Cost mix (full year): raw materials ₹19.41Cr; employee cost ₹10.25Cr; depreciation ₹52.5Lakh; other expenses ₹8.89Cr. Basis: consolidated annual results.

Bafna Pharmaceuticals Ltd Quaterly Results Key Takeaways

Bafna Pharmaceuticals Ltd reported ₹13.13Cr total income from operations in Mar 2020, softer than ₹10.93Cr in Dec 2019 but higher than ₹13.07Cr in Dec 2018. Operating profit (before other income, interest and exceptional items) was ₹3.57Cr; with other income of ₹-₹67.1Lakh, profit before interest and tax came to ₹2.21Cr. Interest expense was ₹2.5Lakh, taking profit before tax to ₹2.18Cr. After tax of ₹1.58Cr, profit after tax stood at ₹60.5Lakh (vs ₹-₹22.33Cr in Dec 2019 and ₹6.3Lakh in Dec 2018).